RMC No. 131-2022: Mandatory Update to Offline eBIRForms Package Version 7.9.3 for Philippine Taxpayers

RMC No. 131-2022 mandates the update to Offline eBIRForms 7.9.3 with new ATCs for International Carriers and requires official taxpayer e-mails for electronic BIR communications. Businesses and individual taxpayers in the Philippines must immediately update to the Offline eBIRForms Package Version 7.9.3 to ensure compliance with the latest BIR requirements. The new package introduces critical […]

RMC No. 130-2022: Deadline Extension for eFiling and ePayment of September 26, 2022 Tax Returns

RMC No. 130-2022 extends the deadline to September 27, 2022 for eFiling and payment of September 26, 2022 tax returns (BIR Forms 2550M, 2550Q, 2551Q) and related reportorial documents. Businesses and taxpayers must act immediately: the deadline for eFiling and ePayment of certain September 26, 2022 tax returns has been extended by one day. This […]

RMC No. 129-2022: Updates to VAT-Exempt Medicines List Affecting Mental Health Prescriptions

RMC No. 129-2022 updates the VAT-exempt medicines list under the CREATE Act, removing certain mental health medicines and requiring businesses to apply 12% VAT immediately. Businesses in the pharmaceutical sector, healthcare providers, and distributors must take immediate note: certain medicines previously exempt from VAT under Republic Act No. 11534 (CREATE Act) are now removed from […]

RMC No. 128-2022: Lost BIR eCAR Form for Real Property Transfers with Serial No. eCR201900303569 Cancelled and Invalidated

RMC No. 128-2022 cancels lost BIR Form No. 2313-R Serial No. eCR201900303569, making related real property transfer transactions invalid. Businesses, property sellers, buyers, brokers, banks, developers, and accountants handling real property transfers should immediately verify that no transaction relies on BIR Form No. 2313-R with Serial Number eCR201900303569, because that specific Electronic Certification Authorizing Registration […]

RMC No. 119-2022: VAT Exemption for Newly Endorsed COVID-19 Medicines

RMC No. 119-2022 adds Nirmatrelvir + Ritonavir 150 mg + 100 mg tablets for COVID-19 to the VAT-exempt list, effective from FDA publication, impacting healthcare providers and distributors. Businesses and healthcare providers must update their VAT-exempt inventory immediately: the Food and Drug Administration has added Nirmatrelvir + Ritonavir 150 mg + 100 mg film-coated tablets […]

RMC No. 116-2022: Updated VAT-Exempt Medicines List for Hypertension, Diabetes, Kidney Disease, Mental Illness, Cancer, and Deleted COVID-19 Medicines

RMC No. 116-2022 updates the VAT-exempt medicines list under CREATE, adding certain chronic disease medicines and deleting some COVID-19 medicines. Pharmacies, hospitals, clinics, distributors, importers, and accounting teams handling medicines must immediately check whether their products remain VAT-exempt, newly qualify for VAT exemption, or have been removed from the VAT-exempt list. RMC No. 116-2022 confirms […]

RMC No. 115-2022: Resumption of Tax Compliance Verification Drives for Businesses and Taxpayers

RMC No. 115-2022 lifts the suspension on Mission Orders for TCVDs, allowing BIR officers to verify taxpayer compliance under the NIRC, effective July 28, 2022. Revenue officers are now authorized to resume conducting Tax Compliance Verification Drives (TCVD), lifting the previous suspension on Mission Orders. Businesses and taxpayers must be prepared for BIR verification activities […]

RMC No. 113-2022: Updates to VAT-Exempt Medicines under the CREATE Act Affecting COVID-19 Treatments

RMC No. 113-2022 updates the VAT-exempt medicines list under the CREATE Act, correcting and deleting certain COVID-19 treatments, effective July 1, 2022. Businesses must adjust VAT filings accordingly. Businesses dealing with pharmaceutical sales must immediately review their VAT compliance for medicines prescribed for COVID-19. Recent updates endorsed by the Food and Drug Administration now correct […]

RMC No. 112-2022: FDA-Endorsed Updates to VAT-Exempt Medicines Affecting Tuberculosis Treatments

RMC No. 112-2022 updates the VAT-exempt medicines list under the CREATE Act, adding tuberculosis medicines and removing COVID-19 medicines, affecting tax compliance for healthcare providers. Businesses in the pharmaceutical and healthcare sectors must immediately update their records and compliance processes due to the newly endorsed changes to the VAT-exempt medicines list. Certain medicines prescribed for […]

RMC No. 103-2022: Temporary BOI Relief for Typhoon Odette-Affected RBEs on Start of Commercial Operations and Income Tax Holiday Availment

RMC No. 103-2022 allows BOI temporary measures for Typhoon Odette-affected RBEs, including ITH reckoning movement and deferment until Dec. 21, 2022. Registered Business Enterprises affected by Typhoon Odette must immediately review whether their Board of Investments registration, start of commercial operations, and Income Tax Holiday availment were disrupted, because RMC No. 103-2022 publishes the temporary […]